These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11429407)

  • 1. Cross-linking of human multidrug resistance P-glycoprotein by the substrate, tris-(2-maleimidoethyl)amine, is altered by ATP hydrolysis. Evidence for rotation of a transmembrane helix.
    Loo TW; Clarke DM
    J Biol Chem; 2001 Aug; 276(34):31800-5. PubMed ID: 11429407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2003 Oct; 278(41):39706-10. PubMed ID: 12909621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2007 Aug; 46(32):9328-36. PubMed ID: 17636884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil.
    Loo TW; Clarke DM
    J Biol Chem; 2001 May; 276(18):14972-9. PubMed ID: 11279063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates.
    Loo TW; Clarke DM
    J Biol Chem; 1996 Nov; 271(44):27482-7. PubMed ID: 8910331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12.
    Loo TW; Clarke DM
    J Biol Chem; 1997 Aug; 272(34):20986-9. PubMed ID: 9261097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2003 Apr; 278(16):13603-6. PubMed ID: 12609990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate.
    Loo TW; Clarke DM
    J Biol Chem; 1997 Dec; 272(51):31945-8. PubMed ID: 9405384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanadate trapping of nucleotide at the ATP-binding sites of human multidrug resistance P-glycoprotein exposes different residues to the drug-binding site.
    Loo TW; Clarke DM
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3511-6. PubMed ID: 11891276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2004 Feb; 279(9):7692-7. PubMed ID: 14670948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The packing of the transmembrane segments of human multidrug resistance P-glycoprotein is revealed by disulfide cross-linking analysis.
    Loo TW; Clarke DM
    J Biol Chem; 2000 Feb; 275(8):5253-6. PubMed ID: 10681495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane.
    Loo TW; Clarke DM
    J Biol Chem; 1999 Dec; 274(50):35388-92. PubMed ID: 10585407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of the most common cystic fibrosis mutation (Delta F508) into human P-glycoprotein disrupts packing of the transmembrane segments.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2002 Aug; 277(31):27585-8. PubMed ID: 12070134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permanent activation of the human P-glycoprotein by covalent modification of a residue in the drug-binding site.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2003 Jun; 278(23):20449-52. PubMed ID: 12711602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of residues in the drug translocation pathway of the human multidrug resistance P-glycoprotein by arginine mutagenesis.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2009 Sep; 284(36):24074-87. PubMed ID: 19581304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2006 Oct; 399(2):351-9. PubMed ID: 16813563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the dimensions of the drug-binding domain of human P-glycoprotein using thiol cross-linking compounds as molecular rulers.
    Loo TW; Clarke DM
    J Biol Chem; 2001 Oct; 276(40):36877-80. PubMed ID: 11518701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
    Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
    Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of residues within the drug-binding domain of the human multidrug resistance P-glycoprotein by cysteine-scanning mutagenesis and reaction with dibromobimane.
    Loo TW; Clarke DM
    J Biol Chem; 2000 Dec; 275(50):39272-8. PubMed ID: 11013259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 2002 Nov; 277(46):44332-8. PubMed ID: 12223492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.